ATTGENO AB
Developing targeted nitric oxide delivery drugs for critical care applications.
Oversigt
- 1–4
- Medarbejdere
- ≤1t SEK
- Omsætning
- 2005
- Grundlagt
Beskrivelse
Attgeno is a Swedish biotechnology company focused on saving patient lives through advanced drug delivery systems. Their core mission revolves around the targeted delivery of nitric oxide (NO), a vital molecule in various physiological processes. The company is pioneering the third generation of NO...